Related Experiment Videos

Treatment of genitourinary rhabdomyosarcoma in children

The Journal of Urology
|August 1, 1984
PubMed

Insights

Combined therapy including surgery, radiotherapy, and chemotherapy offers hope for children with genitourinary rhabdomyosarcoma. Many survivors retain a functional bladder, highlighting the effectiveness of tailored treatment approaches.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Rhabdomyosarcoma is a rare childhood cancer affecting pelvic organs.
  • Treatment for genitourinary rhabdomyosarcoma requires a multidisciplinary approach.

Purpose of the Study:

  • To evaluate the outcomes of combined modality therapy for genitourinary rhabdomyosarcoma in children.
  • To assess the impact of different treatment sequences on survival and bladder function.

Main Methods:

  • Retrospective analysis of 27 children with bladder, prostate, uterus, cervix, or vaginal rhabdomyosarcoma.
  • Treatment included surgery, radiotherapy, and multi-drug chemotherapy in various combinations and sequences.

Main Results:

  • 18 of 27 patients (67%) survived with a median follow-up of 86 months.
  • 9 patients (33%) retained a functional bladder.
  • Extirpative surgery followed by adjuvant chemotherapy was highly effective for local control and survival.

Conclusions:

  • Combined modality treatment, particularly with initial surgery, improves survival rates for pediatric genitourinary rhabdomyosarcoma.
  • Preservation of bladder function is achievable in a significant proportion of patients.
  • Multidisciplinary management is crucial for optimizing outcomes in these rare pediatric cancers.

Related Concept Videos